MX2010007577A - Preparacion nutriceutica o farmaceutica revestida con una sustancia activa mejorada liberada en el colon. - Google Patents

Preparacion nutriceutica o farmaceutica revestida con una sustancia activa mejorada liberada en el colon.

Info

Publication number
MX2010007577A
MX2010007577A MX2010007577A MX2010007577A MX2010007577A MX 2010007577 A MX2010007577 A MX 2010007577A MX 2010007577 A MX2010007577 A MX 2010007577A MX 2010007577 A MX2010007577 A MX 2010007577A MX 2010007577 A MX2010007577 A MX 2010007577A
Authority
MX
Mexico
Prior art keywords
group
active substance
colon
substance release
coated pharmaceutical
Prior art date
Application number
MX2010007577A
Other languages
English (en)
Inventor
Hans-Ulrich Petereit
Hema Ravishankar
Shraddha Bodinge
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of MX2010007577A publication Critical patent/MX2010007577A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Abstract

La presente invención trata sobre una preparación farmacéutica o nutricéutica que consta de a) un núcleo que contiene una sustancia farmacéutica o nutricéuticamente activa; y b) una capa controladora interna que rodea al núcleo y que consta de i) una o una mezcla de cierta cantidad de copolímeros de (met) acrilato que porta un grupo catiónico o un grupo que puede convertirse en un grupo catiónico; y ii) una o una mezcla de cierta cantidad de polímeros o copolímeros que porta un grupo aniónico o un grupo que puede convertirse en un grupo aniónico; y c) una capa controladora exterior que consta de una o una mezcla de cierta cantidad de polímeros o copolímeros que porta un grupo aniónico o un grupo que puede convertirse en un grupo aniónico y a tabletas o cápsulas que constan de lo mismo.
MX2010007577A 2008-01-10 2008-02-01 Preparacion nutriceutica o farmaceutica revestida con una sustancia activa mejorada liberada en el colon. MX2010007577A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN95CH2008 2008-01-10
PCT/EP2008/051236 WO2009086940A1 (en) 2008-01-10 2008-02-01 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon

Publications (1)

Publication Number Publication Date
MX2010007577A true MX2010007577A (es) 2010-08-04

Family

ID=39798120

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010007577A MX2010007577A (es) 2008-01-10 2008-02-01 Preparacion nutriceutica o farmaceutica revestida con una sustancia activa mejorada liberada en el colon.

Country Status (14)

Country Link
US (1) US9237760B2 (es)
EP (1) EP2230932B1 (es)
JP (1) JP5409651B2 (es)
KR (1) KR101500792B1 (es)
CN (1) CN101877971A (es)
BR (1) BRPI0822026B8 (es)
CA (1) CA2711473C (es)
ES (1) ES2626078T3 (es)
HU (1) HUE034848T2 (es)
IL (1) IL205488A (es)
MX (1) MX2010007577A (es)
PL (1) PL2230932T3 (es)
SI (1) SI2230932T1 (es)
WO (1) WO2009086940A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0721654B8 (pt) * 2007-05-07 2022-07-05 Evonik Roehm Gmbh formas de dosagem sólida compreendendo um revestimento entérico com liberação acelerada do fármaco, seu método de fabricação e uso
US20150164920A1 (en) * 2012-03-30 2015-06-18 Laboratorios Del Dr. Esteve S.A. Controlled release formulation comprising mesalamine
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
ES2919874T3 (es) * 2014-09-24 2022-07-28 Vital Beverages Global Inc Composiciones y métodos para el suministro selectivo en el tubo gastrointestinal
WO2016077832A2 (en) 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
US10980751B2 (en) 2015-06-05 2021-04-20 Evonik Operations Gmbh Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
MX2018002586A (es) 2015-09-01 2020-11-24 First Wave Bio Inc Composiciones para usarse en el tratamiento de afecciones asociadas a una repsuesta inflamatoria anómala.
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
WO2017173068A1 (en) * 2016-03-30 2017-10-05 University Of Maryland, Baltimore Microparticulate system for colonic drug delivery
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US20190008779A1 (en) * 2017-05-11 2019-01-10 Gemphire Therapeutics Inc. Gemcabene compositions and methods of use thereof
JP7336187B2 (ja) * 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物
BR112022011055A2 (pt) 2019-12-11 2022-08-23 Evonik Operations Gmbh Forma de dosagem para uso no tratamento ou na prevenção de uma doença
US20230102999A1 (en) 2020-01-10 2023-03-30 First Wave Bio, Inc. Deuterated niclosamide
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
WO2021188564A1 (en) 2020-03-16 2021-09-23 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64726B1 (en) * 1987-11-20 1995-08-23 Elan Corp Plc Pharmaceutical formulations for preventing drug tolerance
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
DE19845358A1 (de) 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
DE10013029A1 (de) 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
DE10149674A1 (de) * 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
DE10250543A1 (de) 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
DE10353196A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
DE10353186A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
GB0403098D0 (en) * 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
BRPI0621996B8 (pt) * 2006-08-18 2022-07-05 Evonik Roehm Gmbh preparação farmacêutica compreendendo um núcleo com um ingrediente ativo e com um ácido orgânico e/ou com o sal de um ácido orgânico, e um revestimento que envolve o núcleo e que compreende um ou mais copolímeros de (met)acrilato, e seu uso.
DE102007009243A1 (de) * 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets
BRPI0721654B8 (pt) 2007-05-07 2022-07-05 Evonik Roehm Gmbh formas de dosagem sólida compreendendo um revestimento entérico com liberação acelerada do fármaco, seu método de fabricação e uso

Also Published As

Publication number Publication date
ES2626078T3 (es) 2017-07-21
HUE034848T2 (en) 2018-03-28
IL205488A0 (en) 2010-12-30
US20100247639A1 (en) 2010-09-30
BRPI0822026A2 (pt) 2014-10-07
EP2230932B1 (en) 2017-03-29
CA2711473C (en) 2016-01-26
KR101500792B1 (ko) 2015-03-09
BRPI0822026B1 (pt) 2019-05-07
CA2711473A1 (en) 2009-07-16
IL205488A (en) 2016-08-31
JP5409651B2 (ja) 2014-02-05
US9237760B2 (en) 2016-01-19
CN101877971A (zh) 2010-11-03
SI2230932T1 (sl) 2017-07-31
WO2009086940A1 (en) 2009-07-16
EP2230932A1 (en) 2010-09-29
BRPI0822026B8 (pt) 2021-05-25
PL2230932T3 (pl) 2017-09-29
JP2011509264A (ja) 2011-03-24
KR20100103566A (ko) 2010-09-27

Similar Documents

Publication Publication Date Title
MX2010007577A (es) Preparacion nutriceutica o farmaceutica revestida con una sustancia activa mejorada liberada en el colon.
MX2010007609A (es) Formulacion de capsula.
MX348491B (es) Tableta a prueba de manipulacion que proporciona liberacion inmediata de fármaco.
WO2011101866A3 (en) Gastric retention formulation containing baclofen
DOP2010000273A (es) Preparacion solida de desintegracion oral
ZA201101097B (en) Pharmaceutical composition of n-[2,4-bis (1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide and administration thereof
WO2012013331A3 (en) Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
NZ589437A (en) Immediate release tablet comprising 5-azacytidine and a non-enteric coating applied with an ethanol solvent
WO2011067667A3 (en) Fexofenadine microcapsules and compositions containing them
WO2010127205A3 (en) Fixed dose drug combination formulations
MX2016007134A (es) Composiciones farmaceuticas mejoradas de pimobendan.
CL2012003523A1 (es) Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable.
PL1928431T3 (pl) Kompozycja farmaceutyczna zawierająca karwedilol o kontrolowanym uwalnianiu
WO2010005732A3 (en) Composition and method of preparation of release systems for constant (zero-order) release of active agents
JO2801B1 (en) A pharmaceutical preparation for oral use has the ability to control the release of an active ingredient in the small intestine and the way it is manufactured
CL2009000330A1 (es) Composicion farmaceutica que comprende microcapsulas de sabor enmascarado con un nucleo de ranitidina y al menos dos recubrimientos sobre el; tabla de rapida desintegracion oral; metodo para preparar la composicion farmaceutica; metodo para preparar la tableta, util para tratar o prevenir trastornos gastrointestinales.
PH12016500693B1 (en) Slow-release solid oral compositions
IL205492A (en) Nuclear Pharmaceuticals or Nuclear Pharmaceuticals containing a core and control layer containing a mixture of multi-acrylic copolymer (meta) copolymers, pills or capsules containing them and using them
MX346316B (es) Formulacion farmaceutica o nutraceutica.
EP2452678A3 (en) Pulsatile-release pharmaceutical formulation of dexlansoprazole
MX2010007579A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada.
EA201170880A1 (ru) Таблетка с контролируемым высвобождением с малой дозой активного вещества
MX346466B (es) Comprimido de tipo liberacion controlada que contiene aceclofenaco.
NZ628867A (en) Pharmaceutical formulation containing flupirtine
EA201691986A1 (ru) Фармацевтическая композиция, содержащая аспирин и бисопролол

Legal Events

Date Code Title Description
FG Grant or registration